🟢 Icecure Medical is trading 5.59% up in pre-market amid gains in S&P 500 and Nasdaq futures

Icecure Medical is trading at $2.18 (+5.59%) in pre-market amid broader risk-on sentiment.

• No new company-specific announcement or overnight filing was identified for September 17, 2026.
• S&P 500 futures were up approximately 0.5%, while Nasdaq futures gained about 1.0%.
• IceCure’s September 10 China NMPA approval remains a recent positive backdrop, but coverage does not directly link it to this pre-market move.